Novartis Ag (NVS)

Novartis (NVS) Stock Price & Analysis


NVS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$75.68 - $99.93
Previous Close$98.13
Average Volume (3M)1.49M
Market Cap
Enterprise Value$230.81B
Total Cash (Recent Filing)$143.00M
Total Debt (Recent Filing)$27.91B
Price to Earnings (P/E)26.3
Jan 31, 2024
2.25 (2.3%)
Share Statistics
EPS (TTM)3.61
Shares Outstanding2,119,609,057
10 Day Avg. Volume1,470,246
30 Day Avg. Volume1,491,915
Standard Deviation0.06
Financial Highlights & Ratios
Price to Book (P/B)-129.75
Price to Sales (P/S)4.01
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.96
Enterprise Value/Gross Profit6.35
Enterprise Value/Ebitda18.49
Price Target Upside20.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Ownership Overview

2.10% Mutual Funds
3.42% Other Institutional Investors
94.48% Public Companies and Individual Investors


What was Novartis Ag’s price range in the past 12 months?
Novartis Ag lowest stock price was $75.68 and its highest was $99.93 in the past 12 months.
    What is Novartis Ag’s market cap?
    Currently, no data Available
    When is Novartis Ag’s upcoming earnings report date?
    Novartis Ag’s upcoming earnings report date is Jan 31, 2024 which is in 58 days.
      How were Novartis Ag’s earnings last quarter?
      Novartis Ag released its earnings results on Oct 24, 2023. The company reported $1.74 earnings per share for the quarter, beating the consensus estimate of $1.667 by $0.073.
        Is Novartis Ag overvalued?
        According to Wall Street analysts Novartis Ag’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Novartis Ag pay dividends?
          Novartis Ag pays a Annually dividend of $5.34 which represents an annual dividend yield of 2.32%. See more information on Novartis Ag dividends here
            What is Novartis Ag’s EPS estimate?
            Novartis Ag’s EPS estimate is $1.58.
              How many shares outstanding does Novartis Ag have?
              Novartis Ag has 2,277,477,800 shares outstanding.
                What happened to Novartis Ag’s price movement after its last earnings report?
                Novartis Ag reported an EPS of $1.74 in its last earnings report, beating expectations of $1.667. Following the earnings report the stock price went up 0.232%.
                  Which hedge fund is a major shareholder of Novartis Ag?
                  Among the largest hedge funds holding Novartis Ag’s share is Dodge & Cox. It holds Novartis Ag’s shares valued at 2B.


                    Company Description

                    Novartis Ag

                    Novartis AG develops, manufactures and sells healthcare products. Its two reporting segments are: Innovative Medicines and Sandoz. The Innovative Medicines business develops and sells patented prescription medicines and is made up of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.


                    Top 5 ETFs holding NVS

                    Market Value
                    Smart Score
                    Harvest Healthcare Leaders Income ETF Trust Units B Unhedged
                    Healthcare LdrIncmUn
                    Evolve Global Healthcare Enhanced Yield Fund Trust Units USD Unhedged
                    Evolve Global Healthcare Enhanced Yield Fund
                    Hartford Quality Value ETF
                    Up to five ETFs with an Outperform Smart Score that hold NVS. The ETFs are listed according to market value of NVS within the ETF

                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Merck & Company

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis